Morgan Stanley Remains a Buy on BioNTech SE (BNTX)
Morgan Stanley analyst Terence Flynn maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of ...
One of science’s greatest achievements: how the rapid development of COVID vaccines prepares us for future pandemics
One of the cornerstones of being prepared for the next pandemic is being in the best position possible to design and deploy a ...
BioNTech (BNTX) Presents at Innovation Series: AI Day
Company Conference Call October 1, 2024 9:00 AM ETCompany ParticipantsKarim Beguir - Chief Executive Officer, InstaDeepUğur ...
Yahoo Finance6d
BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day
Provides updates on BioNTech’s strategy to scale and deploy AI-capabilities across the immunotherapy pipeline Highlights InstaDeep’s new near exascale supercomputer, Kyber, with the aim of ...
Google DeepMind, BioNtech Unveil AI Lab Assistants To Revolutionize Scientific Research
This AI aims to facilitate interdisciplinary collaboration and uncover unexpected connections in scientific research.
Doctor Admits Trying to Kill Mother's Partner With Fake COVID Vaccine
Thomas Kwan, initially pleaded not guilty to attempted murder but reversed his plea after prosecutors presented their evidence.
BioNTech SE ADR rises Friday, outperforms market
The BioNTech SE ADR BNTX advanced 2.40% to $122.68 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.90% to 5,751.07 and the ...
BioNTech SE (BNTX) Gets a Buy from Deutsche Bank
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on BioNTech SE (BNTX – Research Report), with ...
BioNTech's Richardson on Drug Pipeline: Vanguards of Health Care
BioNTech has a broad and diversified cancer drug pipeline extending well beyond mRNA based approaches. Sam Fazeli, Senior Health Care Analyst, speaks to Ryan Richardson, Chief Strategy Officer, who ...